Tamar Kinaciyan | Medicine | Best Research Article Award

Dr. Tamar Kinaciyan | Medicine | Best Research Article Award

Department of Dermatotolgy, Medical University of Vienna | Austria

Author Profile

Scopus

Orcid ID

Early Academic Pursuits

Dr. Tamar Kinaciyan embarked on her medical and dermatological journey at the Medical University of Vienna, where she completed her dermatology board examination in 1996 and specialized in environmental medicine and clinical allergology. Her early academic roles included heading the Borrelia-Outpatient Clinic (1994–2000) and directing immune fluorescence microscopy and antigen-mapping laboratories for bullous and connective tissue diseases (1993–1998). She further strengthened her clinical research foundation through diplomas in dermatoscopy, clinical investigation, and lung function analysis, laying a solid groundwork for her career in pediatric dermatology and allergology.

Professional Endeavors

Dr. Kinaciyan’s professional trajectory spans nearly three decades, marked by leadership roles in both clinical and organizational settings. She serves as Head of the Allergy and Pediatric Dermatology Clinics at the Department of Dermatology, Medical University of Vienna, and leads multiple specialized centers, including ACARE, HAE, and UCARE. Her contributions extend to international collaboration through Ga2LEN ACARE Centers and to advocacy for women in science as founder and honorary president of the Women’s Science Network Medicine. She has also held numerous key roles in Austrian and European scientific societies, reflecting her commitment to both clinical excellence and professional mentorship.

Contributions and Research Focus

Dr. Kinaciyan’s research primarily focuses on hereditary angioedema, urticaria, mastocytosis, and pediatric dermatology, alongside investigations into food allergies, latex allergy, drug hypersensitivity, and eczema. She has led and participated in multiple clinical trials, EU projects, and Austrian national studies, including the Austrian Registry of Bradykinin-mediated Angioedema and studies on sublingual immunotherapy for birch pollen-related food allergies. Her work bridges clinical and translational research, advancing diagnostic and therapeutic approaches for rare and complex allergic and dermatologic conditions.

Impact and Influence

Her clinical and research expertise has significantly influenced European and global dermatology and allergology communities. Dr. Kinaciyan has chaired numerous congress sessions, contributed to guideline task forces, and served as an editorial board member for several high-impact journals, including the Journal of Exploration of Asthma & Allergy. Her mentorship and advocacy efforts, particularly through WNW-med, have empowered foreign-trained physicians and supported gender equity in medical sciences, establishing her as both a thought leader and a mentor.

Academic Citations

Dr. Kinaciyan has a strong publication record with 88 peer-reviewed, Medline-indexed articles, totaling an impact factor of 782.704 and an h-index of 28. Her contributions span original research, invited articles, book chapters, and case studies in prestigious journals and texts, reflecting her broad influence across allergology and dermatology.

Legacy and Future Contributions

Dr. Kinaciyan’s legacy lies in her dual commitment to advancing clinical dermatology and fostering the next generation of medical researchers. By integrating cutting-edge research with patient-centered care and promoting inclusive academic networks, she has set a standard for excellence in both practice and mentorship. Moving forward, her continued focus on hereditary angioedema, pediatric dermatology, and clinical allergology promises to deepen scientific understanding and improve patient outcomes globally.

Conclusion

Dr. Tamar Kinaciyan exemplifies a rare combination of clinical acumen, research innovation, and leadership. Her pioneering work in hereditary angioedema and pediatric dermatology, coupled with her dedication to professional development and mentorship, has left an indelible mark on the field. With a prolific publication record, numerous awards, and sustained international impact, she stands as a leading figure whose ongoing contributions continue to advance both science and patient care.

Notable Publications

“Diagnostic difficulties in pediatric annular dermatoses

  • Author: Doris Weiss; Philipp Weber; Amélie Hampel; Julia Tittes; Wolfgang Weninger; Tamar Kinaciyan
  • Journal: Wiener Medizinische Wochenschrift
  • Year: 2024

“The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation

  • Author: Buttgereit T; Aulenbacher F; Gutsche A; Kolkhir P; Weller K; Vera Ayala C; Magerl M; Farkas H; Grumach AS; Aygören-Pürsün E et al.
  • Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • Year: 2024

“Docetaxel‐induced symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing

  • Author: Amélie Hampel; Tamar Kinaciyan
  • Journal: Contact Dermatitis
  • Year: 2024

“Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

  • Author: Reshef A; Buttgereit T; Betschel SD; Caballero T; Farkas H; Grumach AS; Hide M; Jindal AK; Longhurst H; Peter J et al.
  • Journal: The Journal of allergy and clinical immunology
  • Year: 2024

“The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case.

  • Author: Riebenbauer K; Czerny S; Egg M; Urban N; Kinaciyan T; Hampel A; Fidelsberger L; Karlhofer F; Porkert S; Walochnik J et al.
  • Journal: PLoS neglected tropical diseases
  • Year: 2024

 

 

 

Diane Harper | Cancer Prevention | Best Research Article Award

Dr. Diane Harper | Cancer Prevention | Best Research Article Award

University of Michigan | United States

Author Profiles

Scopus

Google Scholar

Dr. Diane Harper: A Distinguished Career in Medicine and Public Health

Early Academic Pursuits

Dr. Diane Harper’s academic foundation reflects an extraordinary blend of science, engineering, and medicine. She earned dual degrees from the Massachusetts Institute of Technology (SB in Chemical Engineering, 1980; SM in Polymerics, 1982) before pursuing her MD at the University of Kansas Medical School (1986). Further strengthening her research expertise, she obtained a Master of Public Health in Biostatistics and Epidemiology (1995). These early academic pursuits equipped her with a unique interdisciplinary perspective, combining rigorous scientific training with clinical and public health applications.

Professional Endeavors

Dr. Harper’s professional career spans clinical practice, academic leadership, and health policy advisory roles. She trained extensively in gynecology, family medicine, oncology, and medical decision-making at renowned institutions such as Harvard, Stanford, UCSF, McMaster University, and the NIH. Her leadership development programs at the University of Michigan, Bellarmine School of Business, and ELAM further advanced her ability to guide teams in academic medicine. Professionally, she has held faculty, research, and advisory positions that allowed her to impact both patient care and the broader medical community.

Contributions and Research Focus

Dr. Harper is internationally recognized for her groundbreaking research on human papillomavirus (HPV) vaccination, cervical cancer prevention, and screening strategies. She has been instrumental in clinical trials and policy discussions on HPV vaccines, often serving as a critical voice in balancing scientific evidence with public health implementation. Her contributions also extend to training physicians in evidence-based medicine, advancing women’s health initiatives, and exploring psychosocial impacts of cancer prevention strategies.

Impact and Influence

Her impact resonates globally-through over 348 invited lectures and more than 137 international talks, she has influenced health policies, vaccination strategies, and screening practices worldwide. From Europe to Africa, Asia to the Americas, her expertise has shaped guidelines and public understanding of HPV prevention. She has also been recognized for integrating patient-centered perspectives into discussions of vaccine efficacy, safety, and accessibility.

Academic Cites and Recognition

Dr. Harper’s research is widely cited in scientific literature, reflecting her role as a thought leader in cancer prevention. She has authored high-impact publications and has been recognized with numerous national and international awards, including the Curtis G. Hames Research Award, STFM Excellence in Education Award, EuroGin Distinguished Service Award for Cancer Prevention, and the Prix Monte-Carlo Femme de l’Année. Her service on boards, advisory groups, and task forces—including the U.S. Preventive Services Task Force-further highlights her scholarly and policy influence.

Legacy and Future Contributions

Dr. Harper’s legacy lies in her dual commitment to advancing science and protecting public health. Her pioneering work on HPV vaccines has saved countless lives and continues to inform cancer prevention strategies worldwide. Looking forward, her contributions are expected to influence the next generation of researchers and policymakers, particularly in refining strategies for cancer screening, ensuring equitable access to vaccines, and fostering evidence-based decision-making in medicine.

Conclusion

Dr. Diane Harper’s career embodies the ideal integration of scientific innovation, clinical expertise, and public health leadership. Her work has not only advanced academic knowledge but has also transformed preventive health strategies on a global scale. As her legacy continues to inspire, her future contributions promise to shape the evolving landscape of cancer prevention and women’s health, leaving an indelible mark on medicine and society.

Notable Publications

"p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions

  • Author: DM Harper, T Paczos, R Ridder, WK Huh
  • Journal: International Journal of Cancer
  • Year: 2025

"Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review

  • Author: DM Harper, JA Navarro-Alonso, FX Bosch, J Paavonen, M Stanley
  • Journal: Human Vaccines & Immunotherapeutics
  • Year: 2025

"Comparison of Human Papillomavirus genotyping by research vs. clinical assay for two self-collection devices

  • Author: DM Harper, AP Young, MC O’Dwyer, M Olorunfemi, A Laurie, A Sen
  • Journal: Cancer Epidemiology
  • Year: 2025

"A Novel Multi-Strain Vaginal Synbiotic Is Effective in Inhibiting Microbes Associated With Vaginal Dysbiosis, Inflammation, and Mucus Barrier Degradation

  • Author: Tawfiq Taleb Tawfiq; Hala Tawaha; Asem Tahtamouni; Nashat Ali Almasria
  • Journal: J Ravel, S Simmons, D Harper
  • Year: 2024

"The Canadian/United States primary care research partnership

  • Author: DM Harper, VR Ramsden
  • Journal: Annals of Family Medicin
  • Year: 2022